Nabriva Therapeutics plc 3 SEC Filings

Filed On	Filing
10 Jul 2023	Form 3: Hogan H Michael Iii, Chief Executive Officer No securities owned
10 Jul 2023	Form 3: Maggio David, Chief Financial Officer No securities owned
07 Oct 2021	Form 3: Guico-Pabia Christine J., Chief Medical Officer No securities owned
15 Sep 2021	Form 3: Naftzger J. Christopher, General Counsel and Corp Sec No securities owned
04 Jun 2021	Form 3: Dalton Lisa, Director No securities owned
04 Jun 2021	Form 3: Corrigan Mark, Director No securities owned
16 Mar 2021	Form 3: Dolan Daniel, Chief Financial Officer No securities owned
27 Jul 2018	Form 3: Schroeder Theodore R, Chief Executive Officer Holds 60,741 shares of Ordinary Shares
27 Mar 2018	Form 3: Schranz Jennifer, Chief Medical Officer No securities owned
16 Jun 2017	Form 3: Crotty Robert, General Counsel & Corp Sec. No securities owned
03 Jan 2017	Form 3: Vivo Capital VIII, Llc, 10% owner Holds 2,079,860 shares of American Depositary Shares
30 Dec 2016	Form 3: Hbm Healthcare Investments (Cayman) Ltd., 10% owner Holds 275,988 shares of Common Stock
30 Dec 2016	Form 3: Wolf John Peter Iii, General Counsel and Corp. Sec. Holds 270 shares of Common Shares
30 Dec 2016	Form 3: Webster Stephen W, Director
30 Dec 2016	Form 3: Seltzer Elyse G., Chief Medical Officer Holds 240 shares of Common Shares
30 Dec 2016	Form 3: Talbot George Harrison, Director Holds 2,849 shares of Common Shares
30 Dec 2016	Form 3: Rowland Charles A Jr, Director
30 Dec 2016	Form 3: Sender Gary, Chief Financial Officer Holds 220 shares of Common Shares
30 Dec 2016	Form 3: Gelone Steven P., Chief Development Officer Holds 1,274 shares of Common Shares
30 Dec 2016	Form 3: Orbimed Advisors Llc, Director and 2 others Holds 167,794 shares of Common Shares

Comments